Matas Medicare Vorte Fri 2 ml

Organization name

PK Benelux BV

SRN

NL-MF-000006672

Manufacturer status

Active

1 warning recorded — scroll inside the panel to see all entries.

• CW999

  Not for pregnant women or while breastfeeding Not for children aged 3 years and younger Do not use Wart Away: • If you are oversensitive to one or more of the ingredients; • In the face (the fluid should never make contact with the eyes or the mucous membrane in the nose or mouth); • For genital warts or in the genital area; • On birthmarks, water warts, open wounds, moles, naevus, senile (brown) warts, plantar warts, darkly coloured, hairy or strange looking warts; • On red, irritated or infected warts; • Immediately after a surgical removal of warts, freezing of warts (cryotherapy) or a laser treatment. This particularly applies when the skin is red or painful after the treatment. In this case you will have to wait for at least 4 weeks, until the redness or inflammation of the skin has fully disappeared. Only then you can start using Wart Away; • During pregnancy or while breastfeeding; • Do not use on warts which occur completely or partly underneath the nail. • Do not use on warts that occur completely or partially on the sole of the feet (plantar warts). Use in combination with drugs: As far as we know, there are no interactions with drugs. Possible side effects: Wart Away may cause some side effects, although not everyone will experience these side effects. The side effects that could occur when using Wart Away are: irritated skin, burning sensation, skin redness or oversensitivity reactions. If any of these side effects becomes serious, or if you notice any side effects not listed in these instructions for use, please consult your doctor or pharmacist.

Primary placement in Germany; available across 1 country total.

Trade name

Matas Medicare Vorte Fri 2 ml

UDI-DI code

D-076157PG

Basic UDI-DI

B-076157PG

Reference / catalog number

076157

Issuing entity

EUDAMED

Risk category

Class IIa

Applicable legislation

MDD [Directive 93/42/EEC on medical devices]

Status

On the market

Quantity

1

Additional product description

To treat nongenital warts (Verruca vulgaris) due to the mechanical destruction of wart tissue

Additional information URL

No additional information URL provided by the manufacturer.

Clinical sizes

No clinical sizes registered for this device.

• Batch number
• Expiration date
• Manufacturing date
• Serial number
• Software identification

D-076157PG

DataMatrix generation currently supports GS1-issued UDIs. HIBCC / ICCBBA support is coming.

European Medical Device Nomenclature — the EU product classification assigned to this device.

• M9002PROTECTIVE DEVICES, LUBRICANTS AND SOOTHING DEVICES (SPRAYS, GELS, FLUIDS AND CREAMS)